The microbiome in urogenital schistosomiasis and induced bladder pathologies

From BugSigDB
Needs review
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Adebayo AS, Suryavanshi MV, Bhute S, Agunloye AM, Isokpehi RD, Anumudu CI, Shouche YS
Journal
PLoS neglected tropical diseases
Year
2017
BACKGROUND: Human schistosomiasis is a highly prevalent neglected tropical disease (NTD) caused by Schistosoma species. Research on the molecular mechanisms influencing the outcomes of bladder infection by Schistosoma haematobium is urgently needed to develop new diagnostics, therapeutics and infection prevention strategies. The objective of the research study was to determine the microbiome features and changes in urine during urogenital schistosomiasis and induced bladder pathologies. METHODOLOGY: Seventy participants from Eggua, southwestern Nigeria provided morning urine samples and were screened for urogenital schistosomiasis infection and bladder pathologies in a cross-sectional study. Highthroughput NGS sequencing was carried out, targeting the 16S V3 region. Filtered reads were processed and analyzed in a bioinformatics pipeline. PRINCIPAL FINDINGS: The study participants (36 males and 34 females, between ages 15 and 65) were categorized into four groups according to status of schistosomiasis infection and bladder pathology. Data analytics of the next-generation sequencing reads revealed that Proteobacteria and Firmicutes dominated and had influence on microbiome structure of both non-infected persons and persons with urogenital schistosomiasis. Furthermore, gender and age influenced taxa abundance independent of infection or bladder pathology. Several taxa distinguished urogenital schistosomiasis induced bladder pathologies from urogenital schistosomiasis infection alone and from healthy persons, including known immune-stimulatory taxa such as Fusobacterium, Sphingobacterium and Enterococcus. Some of these significant taxa, especially Sphingobacterium were projected as markers of infection, while several genera including potentially beneficial taxa such as Trabulsiella and Weissella, were markers of the non-infected. Finally, expected changes in protein functional categories were observed to relate to cellular maintenance and lipid metabolism. CONCLUSION: The urinary microbiome is a factor to be considered in developing biomarkers, diagnostic tools, and new treatment for urogenital schistosomiasis and induced bladder pathologies.

Experiment 1


Needs review

Curated date: 2024/04/24

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Subjects

Location of subjects
Nigeria
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Urine Urine,urine
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Urinary schistosomiasis bladder Schistosomiasis,bladder schistosomiasis,cystitis with bilharziasis,cystitis with bilharziasis (disorder),Schistosoma haematobium,Schistosoma haematobium (& vesical schistosomiasis),Schistosoma haematobium infection,Schistosoma Hematobium Infection,Schistosoma hematobium infection,Schistosoma hematobium infection (disorder),Schistosoma hematobium infectious disease,Schistosomiasis due to schistosoma haematobium,schistosomiasis due to Schistosoma haematobium,Schistosomiasis haematobia,schistosomiasis of bladder,Schistosomiasis of bladder [Ambiguous],urinary bladder schistosomiasis,urinary schistosomiasis,urinary schistosomiasis (disorder),vesical schistosomiasis,Vesical schistosomiasis NOS,Urinary schistosomiasis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Control
Group 1 name Corresponds to the case (exposed) group for case-control studies
Infection-Only
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Urine samples infected with urogenital schistosomiasis
Group 0 sample size Number of subjects in the control (unexposed) group
13
Group 1 sample size Number of subjects in the case (exposed) group
25
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
Recent use of Antibiotics

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Ion Torrent

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Inverse Simpson Modification of Simpsons index D as 1/D to obtain high values in datasets of high diversity and vice versa
unchanged

Signature 1

Needs review

Curated date: 2024/04/25

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 6B

Description: Differentially abundant microbiome between urogenital schistosomiasis (infection-only) and healthy controls

Abundance in Group 1: increased abundance in Infection-Only

NCBI Quality ControlLinks
Aerococcus
Chryseobacterium
Facklamia
Klebsiella
Pseudomonas
Shewanella
unclassified Carnobacteriaceae
unclassified Planococcaceae
Staphylococcus
unclassified Moraxellaceae
Acinetobacter

Revision editor(s): Adenike Oladimeji-Kasumu

Signature 2

Needs review

Curated date: 2024/04/25

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 6B

Description: Differentially abundant microbiome between urogenital schistosomiasis (infection-only) and healthy controls

Abundance in Group 1: decreased abundance in Infection-Only

NCBI Quality ControlLinks
Enterobacter
Edwardsiella
Erwinia
Mycoplana
Photorhabdus
Hafnia
Limnobacter
Weissella
Gardnerella
Psychrobacter
Acinetobacter
unclassified Moraxellaceae
unclassified Bifidobacteriaceae
unclassified Aeromonadales
unclassified Enterobacteriaceae
unclassified Pseudoalteromonadaceae

Revision editor(s): Adenike Oladimeji-Kasumu

Experiment 2


Needs review

Curated date: 2024/04/25

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Advanced
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Urine samples infected with urogenital schistosomiasis induced bladder pathology.
Group 1 sample size Number of subjects in the case (exposed) group
22

Lab analysis

Statistical Analysis

Alpha Diversity

Inverse Simpson Modification of Simpsons index D as 1/D to obtain high values in datasets of high diversity and vice versa
unchanged

Signature 1

Needs review

Curated date: 2024/04/29

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 6A

Description: Differentially abundant microbiome between urogenital schistosomiasis induced bladder pathology (advanced) and healthy controls.

Abundance in Group 1: increased abundance in Advanced

NCBI Quality ControlLinks
Bacteroides
Jeotgalicoccus
Prevotella
Fusobacterium
Veillonella
Aerococcus
Granulicatella
Facklamia
Brevibacterium
Peptoniphilus
Caulobacter
Lactobacillus
Staphylococcus
Acinetobacter
unclassified Cardiobacteriales

Revision editor(s): Adenike Oladimeji-Kasumu

Signature 2

Needs review

Curated date: 2024/04/29

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 6A

Description: Differentially abundant microbiome between urogenital schistosomiasis induced bladder pathology (advanced) and healthy controls.

Abundance in Group 1: decreased abundance in Advanced

NCBI Quality ControlLinks
unclassified Enterococcaceae
unclassified Bifidobacteriaceae
unclassified Pseudoalteromonadaceae
unclassified Enterobacteriaceae
unclassified Moraxellaceae
unclassified Aeromonadales
Enterobacter
Edwardsiella
Weissella
Erwinia
Photorhabdus
Hafnia
Pseudomonas
Staphylococcus
Acinetobacter

Revision editor(s): Adenike Oladimeji-Kasumu

Experiment 3


Needs review

Curated date: 2024/04/29

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Non-Infected
Group 1 name Corresponds to the case (exposed) group for case-control studies
Infected
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Infected with urogenital schistosomiasis
Group 0 sample size Number of subjects in the control (unexposed) group
24
Group 1 sample size Number of subjects in the case (exposed) group
46

Lab analysis

Statistical Analysis

Alpha Diversity

Inverse Simpson Modification of Simpsons index D as 1/D to obtain high values in datasets of high diversity and vice versa
unchanged

Signature 1

Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 5A, 5B

Description: Differentially abundant microbiome genera in urogenital schistosomiasis (infected) and controls (non-infected).

Abundance in Group 1: increased abundance in Infected

NCBI Quality ControlLinks
Acinetobacter
Aerococcaceae
Aerococcus
Bacteroidaceae
Bacteroides
Brevibacteriaceae
Brevibacterium
Carnobacteriaceae
Chryseobacterium
Enterococcaceae
Enterococcus
Facklamia
Fusobacteriaceae
Fusobacterium
Granulicatella
Jeotgalicoccus
Lactobacillaceae
Lactobacillus
Lactococcus
Melissococcus
Moraxellaceae
Peptoniphilus
Prevotella
Prevotellaceae
Staphylococcaceae
Staphylococcus
Streptococcaceae
Tissierellaceae
Veillonella
Veillonellaceae
Weeksellaceae
unclassified Cardiobacteriales
unclassified Carnobacteriaceae

Revision editor(s): Adenike Oladimeji-Kasumu

Signature 2

Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 5A, 5B

Description: Differentially abundant microbiome genera in urogenital schistosomiasis (infected) and controls (non-infected).

Abundance in Group 1: decreased abundance in Infected

NCBI Quality ControlLinks
Acinetobacter
Bacillaceae
Bacillus
Bifidobacteriaceae
Caulobacteraceae
Chryseobacterium
Edwardsiella
Enhydrobacter
Enterobacter
Enterobacteriaceae
Erwinia
Gardnerella
Hafnia
Janthinobacterium
Limnobacter
Moraxellaceae
Mycoplana
Oxalobacteraceae
Photorhabdus
Pseudoalteromonadaceae
Psychrobacter
Staphylococcaceae
Staphylococcus
Weeksellaceae
Weissella
unclassified Aeromonadales
unclassified Bifidobacteriaceae
unclassified Pseudoalteromonadaceae

Revision editor(s): Adenike Oladimeji-Kasumu

Experiment 4


Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Pathology only
Group 1 name Corresponds to the case (exposed) group for case-control studies
Advanced
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Urogenital schistosomiasis induced bladder pathology.
Group 0 sample size Number of subjects in the control (unexposed) group
10
Group 1 sample size Number of subjects in the case (exposed) group
22

Lab analysis

Statistical Analysis

Alpha Diversity

Inverse Simpson Modification of Simpsons index D as 1/D to obtain high values in datasets of high diversity and vice versa
unchanged

Signature 1

Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 5D

Description: Differentially abundant microbiome genera in non-infected bladder pathology (pathology-only) and urogenital schistosomiasis induced bladder pathology (advanced).

Abundance in Group 1: increased abundance in Advanced

NCBI Quality ControlLinks
Bacteroides
Prevotella
Jeotgalicoccus
Wautersiella
Veillonella
Fusobacterium
Comamonas
unclassified Cardiobacteriales
Aerococcus
Peptoniphilus
unclassified Pseudomonadaceae
Brevibacterium
Facklamia
Weeksella
Granulicatella
Sphingobacterium
Hylemonella sp.
Lactobacillus
Acinetobacter

Revision editor(s): Adenike Oladimeji-Kasumu

Signature 2

Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 5D

Description: Differentially abundant microbiome genera in non-infected bladder pathology (pathology-only) and urogenital schistosomiasis induced bladder pathology (advanced).

Abundance in Group 1: decreased abundance in Advanced

NCBI Quality ControlLinks
Edwardsiella
unclassified Pseudoalteromonadaceae
Hafnia
unclassified Aeromonadales
unclassified Enterobacteriaceae
Staphylococcus
unclassified Planococcaceae
Enhydrobacter
Pseudomonas
Chryseobacterium
Bacillus
Janthinobacterium
Acinetobacter

Revision editor(s): Adenike Oladimeji-Kasumu

Experiment 5


Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Infection Only
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
urogenital schistosomiasis induced bladder pathology.
Group 0 sample size Number of subjects in the control (unexposed) group
25

Lab analysis

Statistical Analysis

Alpha Diversity

Inverse Simpson Modification of Simpsons index D as 1/D to obtain high values in datasets of high diversity and vice versa
unchanged

Signature 1

Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 5C

Description: Differential microbiome genera between urogenital schistosomiasis (infection-only) and urogenital schistosomiasis induced bladder pathology (advanced).

Abundance in Group 1: increased abundance in Advanced

NCBI Quality ControlLinks
unclassified Pseudomonadaceae
Bacteroides
Prevotella
Jeotgalicoccus
unclassified Moraxellaceae
unclassified Cardiobacteriales
Psychrobacter
Fusobacterium
Veillonella
Granulicatella
Facklamia
Brevibacterium
Peptoniphilus
unclassified Bifidobacteriaceae
Caulobacter
Gardnerella
Sphingobacterium
Wautersiella
Limnobacter
Weeksella
Lactobacillus
Mycoplana
Acinetobacter
Staphylococcus

Revision editor(s): Adenike Oladimeji-Kasumu

Signature 2

Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 5C

Description: Differential microbiome genera between urogenital schistosomiasis (infection-only) and urogenital schistosomiasis induced bladder pathology (advanced).

Abundance in Group 1: decreased abundance in Advanced

NCBI Quality ControlLinks
unclassified Enterococcaceae
unclassified Carnobacteriaceae
Chryseobacterium
Acinetobacter
Staphylococcus
Pseudomonas
unclassified Planococcaceae

Revision editor(s): Adenike Oladimeji-Kasumu

Experiment 6


Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Pathology Only
Group 1 name Corresponds to the case (exposed) group for case-control studies
Infection Only
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Urogenital schistosomiasis infection
Group 0 sample size Number of subjects in the control (unexposed) group
10
Group 1 sample size Number of subjects in the case (exposed) group
25

Lab analysis

Statistical Analysis

Alpha Diversity

Inverse Simpson Modification of Simpsons index D as 1/D to obtain high values in datasets of high diversity and vice versa
unchanged

Signature 1

Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure S2B

Description: Differential abundance in the urine microbiome of persons with urogenital schistosomiasis infection without bladder pathology (infection-only) and pathology without schistosomiasis infection (pathology-only).

Abundance in Group 1: increased abundance in Infection Only

NCBI Quality ControlLinks
Aerococcus
unclassified Pseudomonadaceae
Comamonas
Enterococcus
Chryseobacterium
Acinetobacter

Revision editor(s): Adenike Oladimeji-Kasumu

Signature 2

Needs review

Curated date: 2024/04/30

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure S2B

Description: Differential abundance in the urine microbiome of persons with urogenital schistosomiasis infection without bladder pathology (infection-only) and pathology without schistosomiasis infection (pathology-only).

Abundance in Group 1: decreased abundance in Infection Only

NCBI Quality ControlLinks
unclassified Pseudoalteromonadaceae
Enterobacter
Edwardsiella
Erwinia
Photorhabdus
Caulobacter
unclassified Enterobacteriaceae
Staphylococcus
Enhydrobacter
Chryseobacterium
Bacillus
Janthinobacterium
Psychrobacter
unclassified Moraxellaceae
Acinetobacter

Revision editor(s): Adenike Oladimeji-Kasumu

Experiment 7


Needs review

Curated date: 2024/05/01

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Infected
Group 1 name Corresponds to the case (exposed) group for case-control studies
Non-Infected
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Not infected with urogenital schistosomiasis.
Group 0 sample size Number of subjects in the control (unexposed) group
46
Group 1 sample size Number of subjects in the case (exposed) group
24

Lab analysis

Statistical Analysis

Statistical test
LEfSe

Alpha Diversity

Inverse Simpson Modification of Simpsons index D as 1/D to obtain high values in datasets of high diversity and vice versa
unchanged

Signature 1

Needs review

Curated date: 2024/05/01

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 7

Description: Predicted microbial biomarkers in urogenital schistosomiasis cases (infected) and controls (non-infected).

Abundance in Group 1: increased abundance in Non-Infected

NCBI Quality ControlLinks
Leuconostocaceae bacterium
Weissella
unclassified Enterobacteriaceae
Streptomycetaceae
Peptostreptococcus
Trabulsiella
Peptostreptococcaceae
Anaerococcus
Xenorhabdus

Revision editor(s): Adenike Oladimeji-Kasumu

Signature 2

Needs review

Curated date: 2024/05/01

Curator: Adenike Oladimeji-Kasumu

Revision editor(s): Adenike Oladimeji-Kasumu

Source: Figure 7

Description: Predicted microbial biomarkers in urogenital schistosomiasis cases (infected) and controls (non-infected).

Abundance in Group 1: decreased abundance in Non-Infected

NCBI Quality ControlLinks
Stenotrophomonas
unclassified Bacillales
Sphingobacteriaceae
Sphingobacterium
Sphingobacteriia
Sphingobacteriales

Revision editor(s): Adenike Oladimeji-Kasumu